Method and system for temporal spectral imaging

• US 20060018525A1
• Filed: 07/21/2005
• Published: 01/26/2006
• Est. Priority Date: 07/21/2004
• Status: Abandoned Application

• Current Assignee: NIRx Medical Technologies LLC
• Original Assignee: NIRx Medical Technologies LLC
• Inventors: Barbour, Randall L.
• Application Number:
  US11/186,568
• Publication Number:
  US 20060018525A1
• Time in Patent Office: Days
• US Class Current: 382/128
• CPC Class Codes: A61B 5/0073 by tomography, i.e. reconstruction of 3D images from 2D projections A61B5/0066 takes precedence
• CPC Class Codes: A61B 5/02007 Evaluating blood vessel condition, e.g. elasticity, compliance

Abstract

A method for imaging functional states of tissue associated with provocation dependent tissue-vascular responses is described. In its preferred embodiment the method combines dynamic near infrared optical tomographic imaging with feature extraction methods to produce a composite image whose particulars can serve to differentiate healthy tissue from diseased, monitor tissue response to therapy or measure tissue responses to pharmaceutical agents. When combined with simultaneous multisite optical measurements, the described method can be used to differentiate local and system-wide responses.

Claims

1. A method for imaging tissue in a living subject, comprising:

performing a time series of near-infrared optical measurement using at least one source, at least one detector, and at least one illuminating wavelength to collect time-series optical data; and

using the collected time-series optical data to ascertain different features of the tissue that are associated with different types of tissue-vasculature responses.

2. The method of claim 1, wherein the time-series optical measurement is performed on the subject at rest or the living subject undergoing at least one provocation.

3. The method of claim 1, wherein the time-series optical measurement is obtained using at least one of a plurality of illumination-detection strategies.

4. The method of claim 1, wherein the collected time-series of optical data is combined to produce two-dimensional or three-dimensional maps of tissue-vascular responses.

5. The method of claim 4, wherein the two-dimensional and three-dimensional maps comprise one of a single image and a time-series of images.

6. The method of claim 1, wherein the collected time-series of optical data is processed using tomographic imaging principles to produce a spatially resolved 2D or 3D image.

7. The method of claim 1, wherein the collected time-series of optical data is processed using tomographic imaging principles to produce a spatially resolved image time-series.

8. The method of claim 7, wherein the one of a single image and a time-series of images comprise an image of oxyhemoglobin, deoxyhemoglobin, total hemoglobin, hemoglobin oxygen saturation, tissue water, lipid content, scattering amplitude, or scattering power.

9. The method of claim 1, wherein the collected time-series of optical data is processed using at least one signal processing technique to extract features that quantify the response of tissue to a provocation.

10. The method of claim 5, wherein one of the image and time-series of images is processed using at least one signal processing technique to extract at least one feature that quantifies the response of tissue to a provocation.

11. The method of claim 10, wherein the at least one feature is used to yield multi-dimensional information to further characterize tissue response to provocation.

12. The method of claim 11, wherein the multi-dimensional information is collected simultaneously from a plurality of sites on the living subject.

13. The method of claim 11, wherein the multi-dimensional information is further combined with other concurrent physiological measurements and additionally processed using signal decomposition methods that isolate local tissue-specific responses from system-wide responses.

14. The method of claim 10, wherein the multi-dimensional information is used to detect disease states, monitor tissue response to therapy, or measure tissue response to actions of pharmaceutical agents.

15. The method of claim 1, wherein the collected time-series of optical data is based on measurement of luminescent or fluorescent signals having endogenous origin.

16. The method of claim 1, wherein the collected time-series of optical data is based on measurement of luminescent or fluorescent signals that have been injected into the living subject.